Department of Otolaryngology, Head and Neck Surgery, Klinikum Bielefeld, Teutoburger Straße 50, 33604, Bielefeld, Germany.
Department of Cell Biology, University of Bielefeld, 33615, Bielefeld, Germany.
Stem Cell Rev Rep. 2018 Apr;14(2):277-285. doi: 10.1007/s12015-017-9797-2.
Due to their extraordinarily broad differentiation potential and persistence during adulthood, adult neural crest-derived stem cells (NCSCs) are highly promising candidates for clinical applications, particularly when facing the challenging treatment of neurodegenerative diseases or complex craniofacial injuries. Successful application of human NCSCs in regenerative medicine and pharmaceutical research mainly relies on the availability of sufficient amounts of tissue for cell isolation procedures. Facing this challenge, we here describe for the first time a novel population of NCSCs within the middle turbinate of the human nasal cavity. From a surgical point of view, high amounts of tissue are routinely and easily removed during nasal biopsies. Investigating the presence of putative stem cells in obtained middle turbinate tissue by immunohistochemistry, we observed Nestin/p75/S100/α smooth muscle actin (αSMA) cells, which we successfully isolated and cultivated in vitro. Cultivated middle turbinate stem cells (MTSCs) kept their expression of neural crest and stemness markers Nestin, p75 and S100 and showed the capability of sphere formation and clonal growth, indicating their stem cell character. Application of directed in vitro differentiation assays resulted in successful differentiation of MTSCs into osteogenic and neuronal cell types. Regarding the high amount of tissue obtained during surgery as well as their broad differentiation capability, MTSCs seem to be a highly promising novel neural crest stem cell population for applications in cell replacement therapy and pharmacological research.
由于其具有非常广泛的分化潜能和成年后的持久性,成人神经嵴源性干细胞(NCSCs)是临床应用的极具前景的候选者,尤其是在面对神经退行性疾病或复杂颅面损伤的挑战性治疗时。成功将人 NCSCs 应用于再生医学和药物研究主要依赖于可获得足够数量的组织用于细胞分离程序。为了应对这一挑战,我们首次在人类鼻腔的中鼻甲中描述了一种新型 NCSC 群体。从手术的角度来看,在鼻活检过程中,通常可以很容易地切除大量组织。通过免疫组织化学检测获得的中鼻甲组织中是否存在假定的干细胞,我们观察到巢蛋白/ p75 / S100 /α平滑肌肌动蛋白(αSMA)细胞,我们成功地将其分离并在体外培养。培养的中鼻甲干细胞(MTSCs)保持其神经嵴和干细胞标志物巢蛋白、p75 和 S100 的表达,并显示出球体形成和克隆生长的能力,表明其具有干细胞特性。定向体外分化实验的应用导致 MTSCs 成功分化为成骨细胞和神经元细胞类型。鉴于手术中获得的大量组织以及其广泛的分化能力,MTSCs 似乎是一种极具前景的新型神经嵴干细胞群体,可用于细胞替代治疗和药物研究。